COURSE ID 2581

Out-of-Specification (OOS) Result Investigation

AVAILABLE On-demand
90 Minutes

On-Demand

Offering Price
$ 295
Register Now

You will be redirected to our secure system.

Team Training

When you need on-site attention, we’re not just here to help, we’re there to help—right by your side.

Individual courses are remarkably effective. But sometimes when you have a specific need, it helps to have expert guidance right in the room with you and your team.

In that case, we’re happy to design a custom training for your entire team, whether online—or on-site.

Learn more

Remember – at checkout you can choose to take this course On-demand. We offer a 10% group discount when you register 2 of more attendees (up to 10). Contact us for larger groups.

How to Perform a Compliant, Effective, and In-depth Out of Specification (OOS) Investigation

Some FDA (form 483s) and other regulatory bodies inspectional findings, FDA warning letters, product recalls and plant shutdown (voluntary or involuntary) sometimes relate to incomplete, ineffective, and non-compliant OOS investigations that impact a manufactured product. Per the regulations, all Failures, Deviations, or OOS results investigations regardless of its product impact should be appropriately documented, investigated, and analyzed for the root cause(s), with a justifiable retest plan and an effective corrective action plan. Understanding how to identify a true OOS from other types of Laboratory investigations, Invalid Assays, Known Lab Error, Atypical Events, or Lab Calibration out of Tolerance as well as when to perform a retest based on the findings of the OOS investigation is critical to achieving compliance. It is also critical to know when and how to apply averaging versus an outlier to an original test and re-test data generated during an OOS result. This will allow a product manufacturer to achieve compliance relating to an OOS investigational process.

This 90-minute accredited training will benefit manufacturers of cGMP products in designing an effective, robust and compliant OOS investigation process.

Can’t Make this LIVE Webinar?

Simply select the On Demand option when registering and we will send you access to the recorded version for 30 days. On Demand available within 3 business days after the live offering.

Our LIVE online training offers interactive participation. We highly encourage you to open your microphone and/or webcam during the live course to allow for the free exchange of remarks and questions between attendees and course director.

This webinar will provide a great resource to Pharmaceutical, Biotechnology, Biologics, Drugs, Medical Device, In-vitro Diagnostics

Industry personnel within the following functions:

– Quality Control

– Quality Assurance

– Microbiologist

– Chemist

– Analysts

– Manufacturing

– Validation

– Facilities

– Materials

– Engineering <br

– Vendors/Supplies

– Management

However, if you are already familiar with how to perform an effective out-of-specification investigation and apply its requirements, you may

recommend this webinar to anyone within your company that may require additional knowledge about this subject.

course instructor

Charity Ogunsanya
(Owner/CEO), Pharmabiodevice Consulting LLC

Charity Ogunsanya’s Courses
Charity Ogunsanya has more than 30 years of extensive experience within the Biologics, Pharmaceuticals, Radiopharmaceuticals, Biotechnology and Medical Device Industries and has been the Microbiology, Sterility Assurance, Contamination Control, Aseptic processing, Quality Control Subject Matter Expert (SME) for multiple fortune 100 companies. She has a Bachelor of Science degree in Microbiology from the University of Benin-Nigeria and has a Masters degree from the Advanced Academic Master's Biotechnology Program at the Johns Hopkins University with concentration in Biotechnology/Biodefense. She is the CEO/ Owner of her consulting firm named Pharma biodevice Consulting LLC. Her consultancy provides support to Biologics, Pharmaceuticals, Radiopharmaceuticals, Biotechnology and Medical Device Industries.